Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Parkervision Inc. (PRKR) Leads Small-Cap Stars for July 13

PRKR

Equities.com Small-Cap Stars, our proprietary list of small-cap companies best-positioned for future success, generated returns of 45.32% in 2013. And this year’s list is full of even more small caps potentially poised to make big gains.

Here are today’s top-performing Small-Cap Stars:

Parkervision Inc. ($PRKR)

Parkervision Inc. gained 10% to $1.43 a share. The gains came on a volume of 4,143,760 shares against an average daily volume of 4,023,646 shares. Parkervision Inc. has had a trading range from $7.78 to $1.2 over the last year , it has a 50-day SMA of $3.97, and a 200-day SMA of $4.25.

Parkervision, Inc. is in the business of innovating fundamental wireless technologies. It designs, develops & markets its proprietary radio frequency technologies & products for use in semiconductor circuits for mobile & other wireless applications.

Idera Pharmaceuticals Inc. ($IDRA)

Idera Pharmaceuticals Inc. gained 8.78% to $2.85 a share. The gains came on a volume of 1,359,180 shares against an average daily volume of 1,842,642 shares. Idera Pharmaceuticals Inc. has had a trading range from $6.874 to $0.73 over the last year , it has a 50-day SMA of $2.87, and a 200-day SMA of $3.42.

Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company engaged in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.

Single Touch Systems Inc ($SITO)

Single Touch Systems Inc gained 8.33% to $0.39 a share. The gains came on a volume of 500 shares against an average daily volume of 32,890 shares. Single Touch Systems Inc has had a trading range from $0.695 to $0.29 over the last year , it has a 50-day SMA of $0.39, and a 200-day SMA of $0.49.

Single Touch Systems, Inc., is a mobile media solutions provider serving retailers, advertisers and brands.

Zeltiq Aesthetics Inc. ($ZLTQ)

Zeltiq Aesthetics Inc. gained 6.64% to $14.77 a share. The gains came on a volume of 740,010 shares against an average daily volume of 443,275 shares. Zeltiq Aesthetics Inc. has had a trading range from $24.79 to $5.85 over the last year , it has a 50-day SMA of $16.05, and a 200-day SMA of $16.68.

ZELTIQ Aesthetics Inc is a medical technology company. It develops and commercializes medical products such as CoolSculpting system which is a non-invasive product for the selective reduction of body fat.

Tearlab Corporation ($TEAR)

Tearlab Corporation gained 6.38% to $5.17 a share. The gains came on a volume of 629,715 shares against an average daily volume of 521,091 shares. Tearlab Corporation has had a trading range from $15.18 to $3.8 over the last year , it has a 50-day SMA of $4.64, and a 200-day SMA of $7.49.

TearLab Corp is an in-vitro diagnostic company. It commercializes a proprietary tear testing platform that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film.

Equities.com’s Small-Cap Stars: One Way to Make Your Alpha Shine Bright

Equities.com’s Small-Cap Stars are a portfolio of small-cap companies that our system has identified as being best situated for future success based on their fundamentals. The list is built by looking at small-cap companies that recently made large gains, identifying which fundamental metrics they had in common prior to their growth, running a statistical regression to isolate those metrics most-predictive of future success, and seeking out those small-caps in the current market that best resemble that profile.

Our list of 369 companies represent those that should be in the best position to take advantage of what the market has to offer and have the highest potential to create big returns.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today